Share on StockTwits

Bioanalytical System (NASDAQ:BASI) released its earnings data on Thursday. The company reported ($0.03) earnings per share (EPS) for the quarter, AnalystRatings.NET reports. The company had revenue of $5.91 million for the quarter, compared to the consensus estimate of $5.16 million.

Bioanalytical System (NASDAQ:BASI) traded down 0.39% on Thursday, hitting $2.57. The stock had a trading volume of 39,400 shares. Bioanalytical System has a one year low of $1.25 and a one year high of $3.80. The stock has a 50-day moving average of $2.6 and a 200-day moving average of $2.60. The company’s market cap is $20.5 million.

On the ratings front, analysts at TheStreet downgraded shares of Bioanalytical System from a “hold” rating to a “sell” rating in a research note on Friday, February 21st.

Bioanalytical Systems, Inc and its subsidiaries are engaged in research services and other services related to pharmaceutical development.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.